Document ID: EPA-HQ-OAR-2005-0036-0122
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2006-03-30T05:00Z

Enter
emissions
reductions
here:

2020
2030
NOx
­
­
SO2
­
­
direct
diesel
PM2.5
11,803
20,096
10%
PM2.5
5%
PM2.5
No
PM2.5
Nox
This
spreadsheet
calculates
the
benefits
for
a
given
set
of
Nonroad
Diesel
emissio
the
years
2020
and
2030
(
matching
the
years
in
which
air
quality
modeling
was
co
To
use
the
spreadsheet,
you
will
need
to
enter
the
NOx,
SO2,
and
direct
diesel
PM
in
the
cells
below.
Results
will
appear
in
the
Results
Tables
spreadsheet.
Emissions
Species
Difference
in
Reductions
(
Proposed­
Preliminary)
Ratio
of
Reductions
(
Proposed/
Preliminary)
Preliminary
Proposed
2020
NOx
663,618
0
­
663,618
0
SO2
414,692
0
­
414,692
0
PM2.5
98,121
11,803
­
86,318
0.120290254
2030
NOx
1,009,744
0
­
1,009,744
0
SO2
483,401
0
­
483,401
0
PM2.5
138,208
20,096
­
118,112
0.145404029
Reduction
from
Baseline
Bond
20
Bond
30
2020
50%
PM
Adj.
2020
75%
PM
Adj.

92597
124082
92597
92597
49
59
49
49
23564
28700
11782
5891
2356.4
2870
$
1,479,567,818
$
2,583,349,982
1178.2
1435
$
1,140,445,637
$
2,083,696,130
0
0
$
801,323,456
$
1,584,042,278
45720
63000
sion
reductions
in
conducted)

PM2.5
reductions
INCIDENCE
(
for
transfer
to
Wordperfect
table)

Endpoint
2020
2030
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
500
900
Infant
mortality
(
infants
under
one
year)
1
2
Chronic
bronchitis
(
adults,
26
and
over)
300
600
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
800
1600
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
300
500
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
200
400
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
400
600
Acute
bronchitis
(
children,
8­
12)
800
1400
Asthma
exacerbations
(
asthmatic
children,
6­
18)
10000
20000
Lower
respiratory
symptoms
(
children,
7­
14)
10000
20000
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
7000
13000
Work
loss
days
(
adults,
18­
65)
60000
110000
Minor
restricted
activity
days
(
adults,
age
18­
65)
400000
600000
VALUATION
(
for
transfer
to
Wordperfect
table)

Endpoint
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
3%
discount
rate
(
over
5
year
cessation
lag)
3000
6000
7%
discount
rate
(
over
5
year
cessation
lag)
3000
5000
Infant
mortality
(
infants
under
one
year)
8
11
Chronic
bronchitis
(
adults,
26
and
over)
D
100
300
Non­
fatal
myocardial
infarctionsE
3%
discount
rate
(
over
5
year
follow
up)
80
150
7%
discount
rate
(
over
5
year
follow
up)
80
150
Hospital
Admissions
from
Respiratory
CausesF
5
10
Hospital
Admissions
from
Cardiovascular
CausesG
5
9
Emergency
Room
Visits
for
Asthma
0.1
0.2
Acute
bronchitis
(
children,
8­
12)
0.3
0.6
Asthma
exacerbations
(
asthmatic
children,
6­
18)
0.6
1
Lower
respiratory
symptoms
(
children,
7­
14)
0.2
0.3
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
0.2
0.4
Work
loss
days
(
adults,
18­
65)
9
14
Minor
restricted
activity
days
(
adults,
age
18­
65)
20
40
Recreational
visibility
(
86
Class
I
Areas)
0
0
Monetized
TotalH
3%
discount
rate
3000
6000
7%
discount
rate
3000
6000
WITHOUT
INCOME
GROWTH
ADJUSTMENT
Endpoint
2020
Modeled
(
with
IAQR
updates)

Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
6,231
Infant
mortality
(
infants
less
than
one
year)
14
Chronic
bronchitis
(
adults,
26
and
over)
4,266
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
10,568
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
3,379
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
2,782
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
4,589
Acute
bronchitis
(
children,
8­
12)
10,172
Asthma
exacerbations
(
asthmatic
children,
6­
18)
150,616
Lower
respiratory
symptoms
(
children,
7­
14)
120,986
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
91,900
Work
loss
days
(
adults,
18­
65)
809,799
Minor
restricted
activity
days
(
adults,
age
18­
65)
4,782,848
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
3.0%
33,178,916,083
$
7.0%
29,883,361,014
$
Infant
mortality
(
infants
under
one
year)
81,315,082
$
Chronic
bronchitis
(
adults,
26
and
over)
1,552,127,952
$
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
3.0%
1,031,600,445
$
7.0%
999,331,972
$
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
61,896,292
$
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
65,360,601
$
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
1,495,852
$
Acute
bronchitis
(
children,
8­
12)
3,867,574
$
Asthma
exacerbations
(
asthmatic
children,
6­
18)
6,886,969
$
Lower
respiratory
symptoms
(
children,
7­
14)
2,013,235
$
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
2,419,349
$
Work
loss
days
(
adults,
18­
65)
118,762,123
$
Minor
restricted
activity
days
(
adults,
age
18­
65)
258,357,200
$
Visibility
Base
3%
36,365,018,756
$
Base
7%
33,037,195,215
$

0.912385507
0.904536866
INCIDENCE
ESTIMATES
VALUATION
ESTIMATES
WITH
INCOME
GROWTH
ADJUSTMENT
Endpoint
2020
Modeled
(
with
IAQR
updates)

Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
6,231
Infant
mortality
(
infants
less
than
one
year)
14
Chronic
bronchitis
(
adults,
26
and
over)
4,266
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
10,568
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
3,379
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
2,782
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
4,589
Acute
bronchitis
(
children,
8­
12)
10,172
Asthma
exacerbations
(
asthmatic
children,
6­
18)
150,616
Lower
respiratory
symptoms
(
children,
7­
14)
120,986
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
91,900
Work
loss
days
(
adults,
18­
65)
809,799
Minor
restricted
activity
days
(
adults,
age
18­
65)
4,782,848
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
3.0%
39,841,242,432
$
7.0%
35,883,939,906
$
Infant
mortality
(
infants
under
one
year)
97,643,150
$
Chronic
bronchitis
(
adults,
26
and
over)
1,907,254,828
$
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
3.0%
1,031,600,445
$
7.0%
999,331,972
$
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
61,896,292
$
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
65,360,601
$
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
1,495,852
$
Acute
bronchitis
(
children,
8­
12)
4,122,834
$
Asthma
exacerbations
(
asthmatic
children,
6­
18)
7,341,509
$
Lower
respiratory
symptoms
(
children,
7­
14)
2,146,108
$
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
2,579,026
$
Work
loss
days
(
adults,
18­
65)
118,762,123
$
Minor
restricted
activity
days
(
adults,
age
18­
65)
275,408,775
$
Visibility
Base
3%
43,416,853,975
$
Base
7%
39,427,282,976
$

ROUNDED
VALUES
FOR
COPYING
TO
WORDPERFECT
(
OZONE
BENEFITS
ADDED)

Premature
mortalityC:
Long­
term
exposure
(
adults,
30
and
over)
3%
discount
rate
40000
7%
discount
rate
36000
Infant
mortality
(
infants
under
one
year)
100
Chronic
bronchitis
(
adults,
26
and
over)
1900
INCIDENCE
ESTIMATES
VALUATION
ESTIMATES
Non­
fatal
myocardial
infarctions
3%
discount
rate
1030
7%
discount
rate
1000
Hospital
Admissions
from
Respiratory
Causes
7.4
62
Hospital
Admissions
from
Cardiovascular
Causes
65
Emergency
Room
Visits
for
Asthma
0.03
1.5
Acute
bronchitis
(
children,
8­
12)
4.1
Asthma
exacerbations
(
asthmatic
children,
6­
18)
7.3
Lower
respiratory
symptoms
(
children,
7­
14)
2.1
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
2.6
Work
loss
days
(
adults,
18­
65)
120
Minor
restricted
activity
days
(
adults,
age
18­
65)
­
0.12
280
School
absence
days
(
children,
age
6­
11)
4.8
Worker
productivity
(
outdoor
workers,
age
18­
65)
4.2
Recreational
visibility
(
86
Class
I
Areas)
1300
Agricultural
crop
damage
(
6
crops)
88
3%
total
45000
7%
total
41000
43612
0.969155556
Enter
Emissions
Ratios
(
current/
prelim):
2020
2030
NOx
0.000
0.000
SO2
0.000
0.000
direct
PM
0.120
0.145
2030
Modeled
(
with
IAQR
updates)
2020
Scaled
2030
Scaled
9,967
483
909
17
1
2
6,513
331
594
17,747
819
1,618
5,962
262
544
4,372
216
399
6,932
356
632
15,579
788
1,420
232,169
11,674
21,166
185,451
9,377
16,907
141,447
7,123
12,895
1,161,252
62,766
105,865
6,816,080
370,710
621,386
53,072,907,780
$
2,571,637,137
4,838,375,319
47,801,346,473
$
2,316,204,688
4,357,795,053
100,847,387
$
6,302,583
9,193,721
2,369,540,186
$
120,302,600
216,018,402
1,640,984,742
$
79,957,465
149,599,869
1,596,353,564
$
77,456,394
145,531,082
109,395,162
$
4,797,468
9,972,976
103,164,964
$
5,065,981
9,405,002
2,259,203
$
115,941
205,960
5,923,590
$
299,769
540,022
10,616,022
$
533,796
967,806
3,085,951
$
156,042
281,330
3,723,728
$
187,519
339,473
156,924,552
$
9,205,035
14,305,979
368,187,240
$
20,024,794
33,565,677
57,947,560,507
$
2,818,586,131
$
5,282,771,536
$
52,631,368,022
$
2,560,652,612
$
4,798,122,482
$

0.915878206
0.912385507
0.915878206
0.908229223
0.904536866
0.908229223
2030
Modeled
(
with
IAQR
updates)
2020
Scaled
2030
Scaled
9,967
483
909
6,200
17
1
2
14
6,513
331
594
4,300
17,747
819
1,618
10,600
5,962
262
544
3,400
4,372
216
399
2,800
6,932
356
632
4,600
15,579
788
1,420
10,000
232,169
11,674
21,166
150,000
185,451
9,377
16,907
120,000
141,447
7,123
12,895
92,000
1,161,252
62,766
105,865
810,000
6,816,080
370,710
621,386
4,800,000
65,428,280,711
$
3,088,021,874
5,964,749,093
58,929,499,932
$
2,781,298,589
5,372,289,741
124,324,658
$
7,568,142
11,334,019
2,999,363,968
$
147,827,835
273,436,094
1,640,984,742
$
79,957,465
149,599,869
1,596,353,564
$
77,456,394
145,531,082
109,395,162
$
4,797,468
9,972,976
103,164,964
$
5,065,981
9,405,002
2,259,203
$
115,941
205,960
6,372,006
$
319,553
580,902
11,419,655
$
569,027
1,041,069
3,319,558
$
166,341
302,626
4,005,615
$
199,896
365,171
156,924,552
$
9,205,035
14,305,979
396,059,014
$
21,346,431
36,106,598
70,985,873,807
$
3,365,160,989
$
6,471,405,359
$
64,442,461,849
$
3,055,936,633
$
5,874,877,220
$

65000
59000
120
3000
1640
1600
21
NOTE:
FROM
ABT
O3
RESULTS
109
103
0.06
NOTE:
FROM
ABT
O3
RESULTS
2.3
6.4
11.4
3.3
4
160
4.9
NOTE:
FROM
ABT
O3
RESULTS
400
10
6.9
NOTE:
FROM
ABT
O3
RESULTS
2100
137
NOTE:
FROM
ABT
O3
RESULTS
73000
67000
70763
0.969356164
Benefits
Apportionment
Factors:
(
derived
from
REMSAD
speciated
outputs)
2020
2030
NOx
0.130832
0.167741841
SO2
0.224825
0.205283147
direct
PM
0.644343
0.626975011
0.091164693
10,000
17
6,500
17,700
6,000
4,400
6,900
16,000
230,000
190,000
141,000
1,160,000
6,800,000
ALTERNATIVE
INCOME
ADJUSTMENTS:
LOW
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
3.0%
34,000
$
7.0%
31,000
$
Infant
mortality
(
infants
under
one
year)
84
$
Chronic
bronchitis
(
adults,
26
and
over)
1,700
$
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
3.0%
1,030
$
7.0%
1,000
$
Hospital
admissions
 
Respiratory
(
adults,
62
$
Hospital
admissions
 
Cardiovascular
(
adu
65
$
Emergency
Room
Visits
for
Asthma
(
18
an
1
$
Acute
bronchitis
(
children,
8­
12)
4
$
Asthma
exacerbations
(
asthmatic
children
7
$
Lower
respiratory
symptoms
(
children,
7­
1
2
$
Upper
respiratory
symptoms
(
asthmatic
ch
2
$
Work
loss
days
(
adults,
18­
65)
119
$
Minor
restricted
activity
days
(
adults,
age
1
263
$
Visibility
Base
3%
37,339
$
Base
7%
34,309
$

39,000
$

34,084
$
2,730
$
537
$
er)
HIGH
55,000
$
53,000
$
90,000
$
50,000
$
48,000
$
82,000
$
103
$
129
$
172
$
2,700
$
2,000
$
3,200
$

1,640
$
1,030
$
1,640
$
1,600
$
1,000
$
1,600
$
109
$
62
$
109
$
103
$
65
$
103
$
2
$
1
$
2
$
6
$
4
$
7
$
11
$
8
$
12
$
3
$
2
$
4
$
4
$
3
$
4
$
157
$
119
$
157
$
376
$
296
$
431
$

60,214
$
56,719
$
95,841
$
55,174
$
51,689
$
87,801
$

62,000
$
58,000
$
98,000
$

55,103
$
53,129
$
90,172
$
4,340
$
3,030
$
4,840
$
804
$
572
$
862
$
Endpoint
0­
17
18­
64
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
3.0%
­
$
8,948,770,807
$
7.0%
­
$
8,402,712,199
$
Infant
mortality
97,564,504
$
­
$
Chronic
bronchitis
(
adults,
26
and
over)
­
$
1,104,458,560
$
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
3.0%
­
$
468,976,569
$
7.0%
­
$
444,684,277
$
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
­
$
14,251,334
$
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
­
$
32,784,666
$
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
1,313,087
$
­
$
Acute
bronchitis
(
children,
8­
12)
3,619,545
$
­
$
Asthma
exacerbations
(
asthmatic
children,
6­
18)
6,445,305
$
­
$
Lower
respiratory
symptoms
(
children,
7­
14)
1,884,125
$
­
$
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
2,264,195
$
­
$
Work
loss
days
(
adults,
18­
65)
­
$
111,145,856
$
Minor
restricted
activity
days
(
adults,
age
18­
65)
­
$
241,788,640
$

Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
3.0%
1.201
1.201
7.0%
1.201
1.201
Infant
mortality
1.201
1.201
Chronic
bronchitis
(
adults,
26
and
over)
1.229
1.229
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
3.0%
1.000
1.000
7.0%
1.000
1.000
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
1.000
1.000
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
1.000
1.000
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
1.000
1.000
Acute
bronchitis
(
children,
8­
12)
1.066
1.066
Asthma
exacerbations
(
asthmatic
children,
6­
18)
1.066
1.066
Lower
respiratory
symptoms
(
children,
7­
14)
1.066
1.066
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
1.066
1.066
Work
loss
days
(
adults,
18­
65)
1.000
1.000
Minor
restricted
activity
days
(
adults,
age
18­
65)
1.066
1.066
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
3.0%
­
$
10,745,683,985
$
7.0%
­
$
10,089,976,808
$
Infant
mortality
117,155,456
$
­
$
Chronic
bronchitis
(
adults,
26
and
over)
­
$
1,357,158,679
$
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
­
$
­
$
3.0%
­
$
468,976,569
$
Values
from
BenMAP
Repor
Income
Growth
Adjusted
Valu
2020
(
with
IAQR
updates)
in
1990
in
Income
Growth
Adjustment
Fac
7.0%
­
$
444,684,277
$
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
­
$
14,251,334
$
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
­
$
32,784,666
$
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
1,313,087
$
­
$
Acute
bronchitis
(
children,
8­
12)
3,858,435
$
­
$
Asthma
exacerbations
(
asthmatic
children,
6­
18)
6,870,695
$
­
$
Lower
respiratory
symptoms
(
children,
7­
14)
2,008,477
$
­
$
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
2,413,632
$
­
$
Work
loss
days
(
adults,
18­
65)
­
$
111,145,856
$
Minor
restricted
activity
days
(
adults,
age
18­
65)
­
$
257,746,690
$
Base
Total
­­
3%
133,619,783
$
12,987,747,778
$
Base
Total
­­
7%
133,619,783
$
12,307,748,310
$

Base
Total
­­
3%
0.00255
0.24781
Base
Total
­­
7%
0.00271
0.24922
Development
of
Linear
Age
Apportionment
Trend:
0­
17
18­
64
Slopes
Base
Total
­­
3%
­
0.00004
­
0.00556
Base
Total
­­
7%
­
0.00004
­
0.00557
Intercepts
Base
Total
­­
3%
0.08246
11.47334
Base
Total
­­
7%
0.08732
11.50857
Year
Specific
Age
Apportionment
0­
17
18­
64
Base
Total
­­
3%
2007
0.00306379
0.32005522
2010
0.00294511
0.30338365
2015
0.00274732
0.27559768
2020
0.00254952
0.24781172
2025
0.00235173
0.22002576
2030
0.00215393
0.19223979
Base
Total
­­
7%
2007
0.00325021
0.32167858
2010
0.00312454
0.30495677
2015
0.00291509
0.27708710
2020
0.00270564
0.24921742
2025
0.00249619
0.22134775
2030
0.00228675
0.19347807
Transposed
Year
Specific
Age
Apportionment:
0­
17
Base
Total
­­
3%
Base
Total
­­
7%
2007
0.00306
0.00325
2010
0.00295
0.00312
2015
0.00275
0.00292
Age
Apportionment
2020
0.00255
0.00271
2025
0.00235
0.00250
2030
0.00215
0.00229
18­
64
2007
0.32006
0.32168
2010
0.30338
0.30496
2015
0.27560
0.27709
2020
0.24781
0.24922
2025
0.22003
0.22135
2030
0.19224
0.19348
65+
2007
0.67688
0.67507
2010
0.69367
0.69192
2015
0.72165
0.72000
2020
0.74964
0.74808
2025
0.77762
0.77616
2030
0.80561
0.80424
CPI­
U
All
Medical
2000
172.2
260.8
2001
177.1
272.8
2002
179.9
285.6
2003
184.0
297.1
2004
188.9
310.1
CPI
Adjustment
Factors:
2000$
to
2003$
Endpoint
2020
2030
Premature
mortality:
Long­
term
exposure
(
adults,
30
and
over)
0.03
1.07
1.07
0.07
1.07
1.07
Infant
mortality
1.07
1.07
Chronic
bronchitis
(
adults,
26
and
over)
1.07
1.07
Non­
fatal
myocardial
infarctions
(
adults,
18
and
older)
0.03
1.14
1.14
0.07
1.14
1.14
Hospital
admissions
 
Respiratory
(
adults,
20
and
older)
C
1.14
1.14
Hospital
admissions
 
Cardiovascular
(
adults,
20
and
older)
D
1.14
1.14
Emergency
Room
Visits
for
Asthma
(
18
and
younger)
1.14
1.14
Acute
bronchitis
(
children,
8­
12)
1.07
1.07
Asthma
exacerbations
(
asthmatic
children,
6­
18)
1.07
1.07
Lower
respiratory
symptoms
(
children,
7­
14)
1.07
1.07
Upper
respiratory
symptoms
(
asthmatic
children,
9­
11)
1.07
1.07
Work
loss
days
(
adults,
18­
65)
1.07
1.07
Minor
restricted
activity
days
(
adults,
age
18­
65)
1.07
1.07
65+
0­
17
18­
64
65+

31,936,834,066
$
­
$
12,105,543,393
$
60,128,488,140
$
29,988,031,987
$
­
$
11,366,856,895
$
56,459,416,796
$
­
$
143,967,104
$
­
$
­
$
348,130,688
$
­
$
1,563,924,928
$
653,655,616
$

436,581,816
$
­
$
617,849,544
$
822,637,904
$
432,548,232
$
­
$
586,271,787
$
815,037,568
$
45,661,356
$
­
$
20,097,062
$
86,500,848
$
28,595,772
$
­
$
44,000,948
$
51,935,292
$
­
$
1,983,171
$
­
$
­
$
­
$
5,543,708
$
­
$
­
$
­
$
9,935,212
$
­
$
­
$
­
$
2,888,048
$
­
$
­
$
­
$
3,484,924
$
­
$
­
$
­
$
­
$
159,437,216
$
­
$
­
$
­
$
344,575,232
$
­
$

1.201
1.233
1.233
1.233
6.6055
6.78
1.201
1.233
1.233
1.233
417,792
430,372
1.201
1.233
1.233
1.233
1.229
1.266
1.266
1.266
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.066
1.076
1.076
1.076
360.000
383.76
1.066
1.076
1.076
1.076
42.000
44.772
1.066
1.076
1.076
1.076
16.000
17.056
1.066
1.076
1.076
1.076
25.000
26.65
1.000
1.000
1.000
1.000
1.066
1.076
1.076
1.076
51.000
54.366
38,349,750,346
$
­
$
14,923,713,895
$
74,126,400,179
$
36,009,628,810
$
­
$
14,013,061,180
$
69,603,169,026
$
­
$
177,482,646
$
­
$
­
$
427,782,989
$
­
$
1,979,616,174
$
827,397,279
$
­
$
­
$
­
$
­
$
436,581,816
$
­
$
617,849,544
$
822,637,904
$
ports
alues
income
equivalent
2030
(
with
IAQR
updates)
in
1990
income
equivalent
Factors
432,548,232
$
­
$
586,271,787
$
815,037,568
$
45,661,356
$
­
$
20,097,062
$
86,500,848
$
28,595,772
$
­
$
44,000,948
$
51,935,292
$
­
$
1,983,171
$
­
$
­
$
­
$
5,963,367
$
­
$
­
$
­
$
10,687,308
$
­
$
­
$
­
$
3,106,673
$
­
$
­
$
­
$
3,748,733
$
­
$
­
$
­
$
­
$
159,437,216
$
­
$
­
$
­
$
370,659,577
$
­
$
39,288,372,280
$
202,971,897
$
18,115,374,416
$
75,914,871,501
$
36,944,217,160
$
202,971,897
$
17,173,143,944
$
71,384,040,013
$

0.74964
0.00215
0.19224
0.80561
0.74808
0.00229
0.19348
0.80424
65+

0.00560
0.00562
­
10.55580
­
10.59589
65+

0.67688099
0.69367124
0.72165500
0.74963876
0.77762252
0.80560627
0.67507121
0.69191869
0.71999781
0.74807693
0.77615606
0.80423518
1.037
1.040
1.591
1.705
1.037
1.042
1.591
1.705
1.037
1.020
1.591
1.705
1.121
1.139
1.317
1.371
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
387.252
1.018
1.021
1.147
1.170
45.1794
1.018
1.021
1.147
1.170
17.2112
1.018
1.021
1.147
1.170
26.8925
1.018
1.021
1.147
1.170
1.000
1.000
1.000
1.000
54.8607
1.018
1.021
1.147
1.170